Benefits:

Labrada's NEW Lean Body Hi-Energy Fat Burner attacks fat by a unique pathway that is up to 5X more effective in keeping you on your diet!
All fat loss starts in your gut. If you can control your appetite, you eat less, and lose fat, it's that simple. Ordinary "fat burners" don't burn fat. They simply kill your appetite with a big dose of stimulants. Labrada's NEW Lean Body® Hi Energy Fat Burner goes way further by stopping appetite where it starts... in your gut! Only Lean Body® contains PhosphoLean® a cutting-edge, patented compound of NOPE and EGCG, clinically proven to help you stick to your diet by reducing hunger pangs, diet stress, food cravings, binge eating, and diet depression. Lean Body® also contains powerful stimiulants, along with PEA to increase feelings of well-being, mood enhancing amino acids, and Pikatropin™, a cutting edge "nootropic" that reduces that awful feeling of fatigue you can get during a tough diet.

PhosphoLeanR N-Oleoyl-PE + EGCG (NOPE + EGCG) is a proprietary phosphobioflavonic complex of N-oleoyl-phosphatidyl-ethanolamine (NOPE), which contains oleoyl ethanolamine (OEA) bound to phosphatidylethanolamine (PE), a naturally occurring phospholipid found in animal and vegetable foods, and epigallocatechin gallate (EGCG), from standardized green tea extract.

After oral administration, PhosphoLean® NOPE + EGCG is gastro-protected in the stomach, and in the intestinal tract, OEA, a newly discovered lipid mediator involved in the regulation of feeding, is enzymatically liberated.

Recent research has shown that OEA binds to a cell receptor class called peroxisome-proliferator-activated receptor-alpha (PPAR-alpha) found in the intestinal tract. These receptors, when activated, are responsible for signaling the brain center to decrease appetite and hence to reduce both food intake and body weight gain.

Recent findings from a large study involving 138 obese and overweight men and women on an eight week low calorie diet, conducted by Dr. Mariangela Rondanelli at the University of Pavia in Italy, showed that subjects on PhosphoLean® NOPE + EGCG experienced only a 6% drop out rate vs. a 27% drop put rate for the placebo group.

In addition, sensation of appetite, depressive symptoms, and binge eating severity scores were statistically much more favorable for the PhosphoLeanR NOPE + EGCG group. Finally, insulin resistance and blood lipid markers were also statistically more favorable for this active group as well.

There is an increasing demand for pharmaceutical treatment for overweightness and obesity - lifestyle-associated conditions. Decreasing nutrient absorption, inhibition of appetite, and increasing thermogenesis are all currently being considered as possible pharmacological methods of treatment, while appetite suppression, through discovery of special nutrients and newly discovered metabolic pathways, is now opening new science doors.

The EGCG polyphenols in PhosphoLean® NOPE + EGCG act synergistically with OEA via sympathetic activation of thermogenesis and increased fat oxidation, thus enhancing its weight management effects.

Take 2 capsules preferably before a meal with full glass of water. Please consult with a doctor before taking. Do not exceed 2 capsules per 24 hours.